Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories intangible Assets Amortization Expense ($M) ($M)
Form 8-K Non-GAAP Tables & Form 10-K/10-Q Intangibles Footnote
Latest, FY2025
1,682
Period ended Dec 31, 2025
Change on a year earlier
-10.4%
1,878 in FY2024
History
13 years
Since FY2013
Sources
12
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Intangible Assets Amortization Expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,682 | -10.4% | SEC Filing (0001628280-26-002982) ↗ |
| FY2024 | Dec 31, 2024 | 1,878 | -4.5% | SEC Filing (0001628280-26-002982) ↗ |
| FY2023 | Dec 31, 2023 | 1,966 | -2.3% | SEC Filing (0001628280-25-002092) ↗ |
| FY2022 | Dec 31, 2022 | 2,013 | -1.7% | SEC Filing (0001628280-24-002009) ↗ |
| FY2021 | Dec 31, 2021 | 2,047 | -4.0% | SEC Filing (0001628280-23-001516) ↗ |
| FY2020 | Dec 31, 2020 | 2,132 | +10.1% | SEC Filing (0001104659-22-007648) ↗ |
| FY2019 | Dec 31, 2019 | 1,936 | -11.1% | SEC Filing (0001104659-21-007942) ↗ |
| FY2018 | Dec 31, 2018 | 2,178 | +10.3% | SEC Filing (0001104659-20-005717) ↗ |
| FY2017 | Dec 31, 2017 | 1,975 | +259.1% | SEC Filing (0001104659-19-002848) ↗ |
| FY2016 | Dec 31, 2016 | 550 | -8.5% | SEC Filing (0001104659-18-003691) ↗ |
| FY2015 | Dec 31, 2015 | 601 | +8.3% | SEC Filing (0001104659-17-003920) ↗ |
| FY2014 | Dec 31, 2014 | 555 | -29.8% | SEC Filing (0001104659-16-091861) ↗ |
| FY2013 | Dec 31, 2013 | 791 | – | SEC Filing (0001047469-16-010246) ↗ |
Breakdown
What makes up intangible assets amortization expense ($m)
- Forecasted Annual Intangible Amortization — Year 1 ($M)1,500 · FY2025
- Forecasted Annual Intangible Amortization — Year 2 ($M)1,200 · FY2025
- Forecasted Annual Intangible Amortization — Year 3 ($M)650 · FY2025
- Forecasted Annual Intangible Amortization — Year 4 ($M)608 · FY2025
- Forecasted Annual Intangible Amortization — Year 5 ($M)363 · FY2025
Cite this data
StockData. (2026). Abbott Laboratories Intangible Assets Amortization Expense ($M) ($M), annual FY2013–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/gaap-intang-amort
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.